pentoxifylline has been researched along with Syndrome in 16 studies
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although thrombocytopenia is a recognized side effect of interferon therapy, this very dangerous complication has not been previously reported using interferon for the Kasabach-Merritt syndrome." | 5.33 | Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline. ( de la Hunt, MN, 2006) |
| " It is showed that the use of 100 mg of ladasten, 16 mg of ondansetron orally per day and 50 mg of agomelatine per night is more effective in therapy for fatigue/weakness syndrome in incurable cancer patients compared to standard therapy." | 5.20 | [Optimization of pharmacological therapy for weakness syndrome in incurable patients]. ( Glushchenko, VA; Karitsky, AP; Kvashnin, AV; Rozengard, SA; Ryazankina, AA, 2015) |
| "Isolated limb perfusion (ILP) with recombinant human tumor necrosis factor-alpha (rhTNF-alpha) and melphalan harbors the risk of septic shock-like syndrome." | 5.10 | Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. ( Hohenberger, P; Kettelhack, C; Latz, E; Rezaei, AH; Schlag, PM; Schumann, R, 2003) |
| " Treatment with methotrexate (5 mg/week) and pentoxifylline (300 mg/d) was effective to control oral ulcers, erythema nodosum, and arthritis." | 4.79 | Mouth and genital ulcers with inflamed cartilage (MAGIC syndrome): a case report and literature review. ( Hamai, K; Imai, H; Komatsuda, A; Miura, AB; Mizuki, N; Motegi, M; Ohtani, H, 1997) |
| "Cancer anorexia and cachexia are two distinct syndromes which may have synergistic effects in a patient." | 2.41 | [Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]. ( Gastell, S; Lochs, H; Ockenga, J; Pirlich, M, 2002) |
| "The early inclusion of patients with NAFLD and severe asthenic syndrome in the treatment regimen, in addition to the basic therapy of Cytoflavin, achieved a significantly high therapeutic effect in the form of normalization of the main clinical, laboratory and instrumental parameters, as well as a significant reduction in the manifestations of asthenia." | 1.62 | [Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome]. ( Eremin, MN; Ivolgin, AF; Karakozov, AG; Katenko, SV; Levchenko, OB; Molodova, AI; Pavlov, AI, 2021) |
| "Although thrombocytopenia is a recognized side effect of interferon therapy, this very dangerous complication has not been previously reported using interferon for the Kasabach-Merritt syndrome." | 1.33 | Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline. ( de la Hunt, MN, 2006) |
| "Kasabach-Merritt syndrome is a combination of thrombocytopenia, intravascular coagulation, and a rapid increase in the size of an angioma." | 1.28 | [Kasabach-Merritt syndrome in children]. ( Andry, P; Bodemer, C; Brunelle, F; de Prost, Y; Hubert, P; Nihoul-Fékété, C; Sebag, G; Teillac-Hamel, D, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Pavlov, AI | 1 |
| Ivolgin, AF | 1 |
| Katenko, SV | 1 |
| Eremin, MN | 1 |
| Molodova, AI | 1 |
| Levchenko, OB | 1 |
| Karakozov, AG | 1 |
| Ryazankina, AA | 1 |
| Rozengard, SA | 1 |
| Glushchenko, VA | 1 |
| Karitsky, AP | 1 |
| Kvashnin, AV | 1 |
| Ockenga, J | 1 |
| Pirlich, M | 1 |
| Gastell, S | 1 |
| Lochs, H | 1 |
| Hohenberger, P | 1 |
| Latz, E | 1 |
| Kettelhack, C | 1 |
| Rezaei, AH | 1 |
| Schumann, R | 1 |
| Schlag, PM | 1 |
| Hung, KY | 1 |
| Huang, JW | 1 |
| Tsai, TJ | 1 |
| Hsieh, BS | 1 |
| de la Hunt, MN | 1 |
| Kaz'min, AI | 1 |
| Pavlova, GA | 1 |
| Travkin, AA | 1 |
| Mitskevich, VA | 1 |
| Nürnberg, W | 1 |
| Grabbe, J | 1 |
| Czarnetzki, BM | 1 |
| Maier, U | 1 |
| Szabo, N | 1 |
| Madersbacher, S | 1 |
| Vasquez, EM | 1 |
| Pollak, R | 1 |
| Imai, H | 1 |
| Motegi, M | 1 |
| Mizuki, N | 1 |
| Ohtani, H | 1 |
| Komatsuda, A | 1 |
| Hamai, K | 1 |
| Miura, AB | 1 |
| Weisshaar, E | 1 |
| Claus, G | 1 |
| Friedl, A | 1 |
| Gollnick, H | 1 |
| Gottlöber, P | 1 |
| Krähn, G | 1 |
| Peter, RU | 1 |
| Vicktor, C | 1 |
| Schultz-Ehrenburg, U | 1 |
| Teillac-Hamel, D | 1 |
| Andry, P | 1 |
| Bodemer, C | 2 |
| Hubert, P | 1 |
| Sebag, G | 1 |
| Brunelle, F | 1 |
| Nihoul-Fékété, C | 2 |
| de Prost, Y | 2 |
| Teillac, D | 1 |
| Enjolras, O | 1 |
| de Prost, D | 1 |
4 reviews available for pentoxifylline and Syndrome
| Article | Year |
|---|---|
[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions].
Topics: Adrenal Cortex Hormones; Algorithms; Anorexia; Body Weight; Cachexia; Cyclooxygenase Inhibitors; Die | 2002 |
Peritoneal fibrosing syndrome: pathogenetic mechanism and current therapeutic strategies.
Topics: Dipyridamole; Fibrosis; Humans; Pentoxifylline; Peritoneal Dialysis; Peritoneum; Risk Factors; Syndr | 2005 |
Mouth and genital ulcers with inflamed cartilage (MAGIC syndrome): a case report and literature review.
Topics: Adult; Behcet Syndrome; Drug Therapy, Combination; Female; Genital Diseases, Female; Genotype; HLA A | 1997 |
[Cutaneous radiation syndrome: clinical features, diagnosis and therapy].
Topics: Adrenal Cortex Hormones; Adult; Brazil; Female; Free Radical Scavengers; Georgia (Republic); Humans; | 2000 |
3 trials available for pentoxifylline and Syndrome
| Article | Year |
|---|---|
[Optimization of pharmacological therapy for weakness syndrome in incurable patients].
Topics: Acetamides; Adamantane; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Ant | 2015 |
Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemothera | 2003 |
Effect of oral pentoxyfylline on the OKT3-induced cytokine-release syndrome among renal allograft recipients.
Topics: Administration, Oral; Cytokines; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab | 1996 |
9 other studies available for pentoxifylline and Syndrome
| Article | Year |
|---|---|
[Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome].
Topics: Asthenia; Humans; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Saline Solution; Syndrome | 2021 |
Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline.
Topics: Angiogenesis Inhibitors; Female; Hemangioma, Capillary; Hematologic Agents; Humans; Infant; Interfer | 2006 |
[Trental treatment of spinal and radicular ischemic syndromes in spinal diseases].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Ischemia; Kyphosis; Male; Microcirculation | 1981 |
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline.
Topics: Adult; Antigen-Antibody Complex; Complement C3; Dapsone; Drug Combinations; Drug Resistance; Female; | 1995 |
[Systemic therapy of OAT (oligoasthenoteratozoospermia) syndrome with pentoxifylline].
Topics: Administration, Oral; Adult; Humans; Kallikreins; Long-Term Care; Male; Oligospermia; Pentoxifylline | 1993 |
Atrial myxoma syndrome mimicking Ehrmann-Sneddon syndrome.
Topics: Adult; Aspirin; Brain Stem; Diagnosis, Differential; Echocardiography; Follow-Up Studies; Heart Atri | 1997 |
[Malignant atrophic papulosis (Köhlmeier-Degos): diagnosis, therapy and course].
Topics: Aged; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Pent | 2001 |
[Kasabach-Merritt syndrome in children].
Topics: Aspirin; Child, Preschool; Disseminated Intravascular Coagulation; Embolization, Therapeutic; Hemang | 1992 |
Successful treatment of Kasabach-Merritt syndrome with pentoxifylline.
Topics: Disseminated Intravascular Coagulation; Female; Forearm; Hemangioma; Humans; Infant; Pentoxifylline; | 1991 |